Rocket Lab shares jumped 8.2% after Cantor Fitzgerald reiterated its Overweight rating and $122 price target. Investors are focusing on the company’s upcoming Neutron rocket launch, the planned Iridium acquisition and a record $2.36 billion backlog.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.